Robert F. Kennedy Jr. was forced to walk back his words after he accused a Democratic lawmaker of accepting millions from the ...

To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...

Q&A with Model N's Michael Grosberg drills deeper into the new US drug pricing directives, including challenges in ...

Membrane is a winner in the Innovation, Research & Development, and Environmental categories in the 2025 Pharmaceutical ...

An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...

Gulf Energy Information, a global leader in B2B media, data, and events for the process industries, announced a strategic media partnership with CompareNetworks, a premier media and technology company ...

A Japanese pharmaceutical company is offering money for people’s poop, but only if they produce what they deem as “healthy” ...

A House Energy and Commerce Subcommittee on Health hearing came to a brief halt Tuesday as the Republican chair asked Health ...

Phase 3 Aspire study enrollment on track to complete in 2025 Aurora study to evaluate GTX-102 in other Angelman syndrome genotypes and ages expected to initiate later this year NOVATO, Calif., June 27 ...

In the fast-evolving world of pharmaceutical manufacturing, digital transformation is no longer a distant vision—it is a ...

The Polish government’s new draft law on drug reimbursement aims to streamline procedures, empower patients, and ensure ...

Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Process Validation for Pharmaceutical and Biologics" training has been added to ResearchAndMarkets.com's offering. This FDA Process Validation ...